Central European Journal of Nursing and Midwifery (Mar 2024)

[Article title missing]

  • Othman A. Alfuqaha,
  • Hadeel S. Yaghi,
  • Laila A. Alrawashdeh,
  • Nour B. Rezqallah

DOI
https://doi.org/10.15452/cejnm.2023.14.0021
Journal volume & issue
Vol. 15, no. 1
pp. 1042 – 1049

Abstract

Read online

Aim: To evaluate the efficacy of hydrocolloid dressing in preventing stage two or higher facial pressure injuries associated with the use of noninvasive positive pressure ventilation (NIPPV) devices among critically ill patients. Design: A randomized control trial. Methods: The study included 56 adult patients in intensive care units. The study participants were categorized into two groups consisting of 28 patients in each group. The control group received skincare using a fine mist of water and repositioning of the device every two to four hours, while the intervention group received a hydrocolloid dressing and repositioning of the device every two to four hours. Results: A total of 33.9% of all participants in the study had facial pressure injury. None of the patients in the intervention group who received hydrocolloid dressing developed stage two or higher facial pressure injuries. A total of 32.2% of the control group developed stage two or higher facial pressure injuries. Results indicated that the use of hydrocolloid dressing can significantly prevent the formation of stage two or higher facial pressure injuries (p < 0.001). Conclusion: The study's findings support the use of hydrocolloid dressing as a preventative measure for facial pressure injuries related to NIPPV devices.

Keywords